These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 15817707)

  • 1. Leukocyte apoptosis and its significance in sepsis and shock.
    Wesche DE; Lomas-Neira JL; Perl M; Chung CS; Ayala A
    J Leukoc Biol; 2005 Aug; 78(2):325-37. PubMed ID: 15817707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fas-ligand mediated apoptosis in severe sepsis and shock.
    Ayala A; Lomas JL; Grutkoski PS; Chung S
    Scand J Infect Dis; 2003; 35(9):593-600. PubMed ID: 14620140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role and regulation of apoptosis in sepsis.
    Wesche-Soldato DE; Lomas-Neira JL; Perl M; Jones L; Chung CS; Ayala A
    J Endotoxin Res; 2005; 11(6):375-82. PubMed ID: 16303094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-10 mediation of activation-induced TH1 cell apoptosis and lymphoid dysfunction in polymicrobial sepsis.
    Ayala A; Chung CS; Song GY; Chaudry IH
    Cytokine; 2001 Apr; 14(1):37-48. PubMed ID: 11298491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of TRAIL-induced apoptosis by ectopic expression of antiapoptotic factors.
    Aggarwal BB; Bhardwaj U; Takada Y
    Vitam Horm; 2004; 67():453-83. PubMed ID: 15110190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing of fas-associated death domain protects mice from septic lung inflammation and apoptosis.
    Matsuda N; Yamamoto S; Takano K; Kageyama S; Kurobe Y; Yoshihara Y; Takano Y; Hattori Y
    Am J Respir Crit Care Med; 2009 May; 179(9):806-15. PubMed ID: 19201926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caspase-3 activation, Bcl-2 contents, and soluble FAS-ligand are not related to the inflammatory marker profile in patients with sepsis and septic shock.
    Kriebel F; Wittemann S; Hsu HY; Joos T; Weiss M; Schneider EM
    Ann N Y Acad Sci; 2006 Dec; 1090():168-76. PubMed ID: 17384259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Fas antibody differentially regulates apoptosis in Fas ligand resistant carcinoma lines via the caspase 3 family of cell death proteases but independently of bcl2 expression.
    Crowe DL; Boardman ML; Fong KS
    Anticancer Res; 1998; 18(5A):3163-70. PubMed ID: 9858879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells.
    Sylvester PW; Shah S
    Asia Pac J Clin Nutr; 2005; 14(4):366-73. PubMed ID: 16326643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligation of CD40 potentiates Fas-mediated activation of the cysteine protease CPP32, cleavage of its death substrate PARP, and apoptosis in Ramos-Burkitt lymphoma B cells.
    An S; Yap D; Knox KA
    Cell Immunol; 1997 Nov; 181(2):139-52. PubMed ID: 9398401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
    Izeradjene K; Douglas L; Delaney A; Houghton JA
    Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor protects epithelial-derived cells from tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by inhibiting cytochrome c release.
    Gibson EM; Henson ES; Haney N; Villanueva J; Gibson SB
    Cancer Res; 2002 Jan; 62(2):488-96. PubMed ID: 11809700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt.
    Woo JH; Kim YH; Choi YJ; Kim DG; Lee KS; Bae JH; Min DS; Chang JS; Jeong YJ; Lee YH; Park JW; Kwon TK
    Carcinogenesis; 2003 Jul; 24(7):1199-208. PubMed ID: 12807727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. eNOS protects prostate cancer cells from TRAIL-induced apoptosis.
    Tong X; Li H
    Cancer Lett; 2004 Jul; 210(1):63-71. PubMed ID: 15172122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis signaling pathways in normal T cells: differential activity of Bcl-2 and IL-1beta-converting enzyme family protease inhibitors on glucocorticoid- and Fas-mediated cytotoxicity.
    Moreno MB; Memon SA; Zacharchuk CM
    J Immunol; 1996 Nov; 157(9):3845-9. PubMed ID: 8892614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human retinoblastoma cells are resistant to apoptosis induced by death receptors: role of caspase-8 gene silencing.
    Poulaki V; Mitsiades CS; McMullan C; Fanourakis G; Negri J; Goudopoulou A; Halikias IX; Voutsinas G; Tseleni-Balafouta S; Miller JW; Mitsiades N
    Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):358-66. PubMed ID: 15623796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis.
    Huerta-Yepez S; Vega M; Garban H; Bonavida B
    Clin Immunol; 2006 Sep; 120(3):297-309. PubMed ID: 16784892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of T cell clonal anergy results in resistance, whereas CD28-mediated costimulation primes for susceptibility to Fas- and Bax-mediated programmed cell death.
    Boussiotis VA; Lee BJ; Freeman GJ; Gribben JG; Nadler LM
    J Immunol; 1997 Oct; 159(7):3156-67. PubMed ID: 9317113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-11 antagonizes Fas ligand-mediated apoptosis in IEC-18 intestinal epithelial crypt cells: role of MEK and Akt-dependent signaling.
    Naugler KM; Baer KA; Ropeleski MJ
    Am J Physiol Gastrointest Liver Physiol; 2008 Mar; 294(3):G728-37. PubMed ID: 18202115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of proinflammatory molecules with apoptotic markers and survival in critically ill multiple organ dysfunction patients.
    Papathanassoglou ED; Movnihan JA; Dafni O; Mantzoros CS; Ackerman MH
    Biol Res Nurs; 2003 Oct; 5(2):129-41. PubMed ID: 14531217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.